Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Placental growth factor and adverse obstetric outcomes in a mixed-risk cohort of women screened for preeclampsia in the first trimester of pregnancy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Intrathecal IgM as a Prognostic Marker in Multiple Sclerosis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Short-Term Flow Changes in Monochorionic Survivor Twins after Ultrasound-Guided Umbilical Cord Occlusion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cell-Free Fetal DNA in the Early and Late First Trimester

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Magnetic Resonance Imaging: A New Tool to Optimize the Prediction of Fetal Anemia?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Prenatal detection rate of major congenital heart defects in Copenhagen from 2015 to 2018

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Long-term consequences of prenatal progesterone exposure

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: The study aimed to investigate the association between placental growth factor (PlGF) and adverse obstetric outcomes in a mixed-risk cohort of pregnant women screened for preeclampsia (PE) in the first trimester.

METHODS: We included women with singleton pregnancies screened for PE between April 2014 and September 2016. Outcome data were retrieved from the New South Wales Perinatal Data Collection (NSW PDC) by linkage to the prenatal cohort. Adverse outcomes were defined as spontaneous preterm birth (sPTB) before 37-week gestation, birth weight (BW) below the 3rd centile, PE, gestational hypertension (GH), stillbirth, and neonatal death.

RESULTS: The cohort consisted of 11,758 women. PlGF multiple of the median (MoM) was significantly associated with maternal sociodemographic characteristics (particularly smoking status and parity) and all biomarkers used in the PE first trimester screening model (notably pregnancy-associated plasma protein A MoM and uterine artery pulsatility index [PI] MoM). Low levels of PlGF (<0.3 MoM and <0.5 MoM) were independently associated with sPTB, low BW, PE, GH, and a composite adverse pregnancy outcome score, with odds ratios between 1.81 and 4.44 on multivariable logistic regression analyses.

CONCLUSIONS: Low PlGF MoM levels are independently associated with PE and a range of other adverse pregnancy outcomes. Inclusion of PlGF should be considered in future models screening for adverse pregnancy outcomes in the first trimester.

OriginalsprogEngelsk
TidsskriftFetal Diagnosis and Therapy
Vol/bind48
Udgave nummer4
Sider (fra-til)304-312
Antal sider9
ISSN1015-3837
DOI
StatusUdgivet - apr. 2021

ID: 65563088